State of New Jersey Common Pension Fund D Cuts Stock Holdings in Chemed Co. (NYSE:CHE)

State of New Jersey Common Pension Fund D cut its stake in Chemed Co. (NYSE:CHE) by 32.4% in the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 5,260 shares of the company’s stock after selling 2,517 shares during the period. State of New Jersey Common Pension Fund D’s holdings in Chemed were worth $2,854,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Norges Bank acquired a new stake in Chemed in the 4th quarter valued at about $92,359,000. TD Asset Management Inc raised its holdings in Chemed by 164.3% in the fourth quarter. TD Asset Management Inc now owns 205,777 shares of the company’s stock valued at $120,328,000 after acquiring an additional 127,934 shares in the last quarter. Epoch Investment Partners Inc. lifted its stake in Chemed by 85.2% in the fourth quarter. Epoch Investment Partners Inc. now owns 152,162 shares of the company’s stock worth $88,977,000 after acquiring an additional 70,001 shares during the last quarter. Impax Asset Management Group plc lifted its stake in Chemed by 19.5% in the second quarter. Impax Asset Management Group plc now owns 317,943 shares of the company’s stock worth $172,510,000 after acquiring an additional 51,974 shares during the last quarter. Finally, ProShare Advisors LLC grew its holdings in Chemed by 6,288.9% during the 1st quarter. ProShare Advisors LLC now owns 50,600 shares of the company’s stock worth $32,482,000 after acquiring an additional 49,808 shares in the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

Insider Activity at Chemed

In other news, EVP Nicholas Michael Westfall sold 2,000 shares of the business’s stock in a transaction that occurred on Tuesday, July 30th. The shares were sold at an average price of $561.58, for a total transaction of $1,123,160.00. Following the completion of the sale, the executive vice president now owns 5,990 shares in the company, valued at approximately $3,363,864.20. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. In other news, EVP Nicholas Michael Westfall sold 2,000 shares of Chemed stock in a transaction dated Tuesday, July 30th. The stock was sold at an average price of $561.58, for a total transaction of $1,123,160.00. Following the sale, the executive vice president now owns 5,990 shares in the company, valued at $3,363,864.20. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director George J. Walsh III sold 200 shares of the business’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $577.95, for a total value of $115,590.00. Following the completion of the sale, the director now directly owns 3,446 shares of the company’s stock, valued at $1,991,615.70. The disclosure for this sale can be found here. Insiders sold 6,744 shares of company stock valued at $3,828,231 over the last three months. 3.32% of the stock is owned by corporate insiders.

Chemed Trading Down 0.0 %

Shares of NYSE:CHE opened at $577.59 on Thursday. The company has a market cap of $8.74 billion, a PE ratio of 31.09, a P/E/G ratio of 2.31 and a beta of 0.44. The company’s 50 day moving average is $567.45 and its two-hundred day moving average is $578.35. Chemed Co. has a 52 week low of $497.36 and a 52 week high of $654.62.

Chemed (NYSE:CHE) last posted its earnings results on Wednesday, July 24th. The company reported $5.47 EPS for the quarter, missing the consensus estimate of $5.59 by ($0.12). The business had revenue of $595.88 million during the quarter, compared to analysts’ expectations of $599.20 million. Chemed had a net margin of 12.88% and a return on equity of 29.21%. The business’s quarterly revenue was up 7.6% compared to the same quarter last year. During the same period last year, the company earned $4.71 EPS. As a group, equities research analysts expect that Chemed Co. will post 21.77 EPS for the current year.

Chemed Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 30th. Investors of record on Monday, August 12th were issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a yield of 0.35%. This is an increase from Chemed’s previous quarterly dividend of $0.40. The ex-dividend date was Monday, August 12th. Chemed’s dividend payout ratio is 10.76%.

About Chemed

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.